CONSONANCE CAPITAL PARTNERS, LP
CONSONANCE CAPITAL PARTNERS, LP is a Series C+ and buyout fund in the US investing in healthcare-tech.
- Stages
- Series C+, buyout
- Sectors
- healthcare-tech
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2005
- Assets under management
- >$1.3B
Check size not disclosed
Thesis
Consonance Capital Partners (CCP) is a private equity firm exclusively focused on the U.S. healthcare industry, founded in 2005. They invest in middle-market companies with revenues typically between $25 million and $500 million, aiming to build a more efficient and higher-quality healthcare system. CCP employs a thematic strategy, concentrating on select high-growth healthcare segments and partnering with strong management teams. Their investment approach includes growth equity, leveraged buyouts, carve-outs, recapitalizations, and special situations. The firm has raised over $1.3 billion across two funds, with their latest fund closing at $856 million.
Common questions
Does CONSONANCE CAPITAL PARTNERS, LP invest at the Series C+ stage?
Yes. CONSONANCE CAPITAL PARTNERS, LP lists Series C+ and buyout among the stages it invests in.
Where does CONSONANCE CAPITAL PARTNERS, LP invest?
CONSONANCE CAPITAL PARTNERS, LP invests in the US.